Global HPAPI Market to reach USD 41.08 billion by 2027.

Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size study, by Product (Synthetic, Biotech), by Manufacturer (In-house, Outsourced), by Drug Type (Generic, Innovative), Therapeutic Application (Oncology, Hormonal, Glaucoma and Others) and Regional Forecasts 2021-2027
Product Code:  HALDAT_94624699
Chapter 1.Executive Summary 
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. HPAPI Market, by Product, 2019-2027 (USD Billion)
1.2.2. HPAPI Market, by Manufacturer, 2019-2027 (USD Billion)
1.2.3. HPAPI Market, by Drug Type, 2019-2027 (USD Billion)
1.2.4. HPAPI Market, by Therapeutic, 2019-2027 (USD Billion)
1.2.5. HPAPI Market, by, 2019-2027 (USD Billion)
1.2.6. HPAPI Market, by, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global HPAPI Market Definition and Scope 
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global HPAPI Market Dynamics 
3.1. HPAPI Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase demand from oncology patients
3.1.1.2. Rise in R&D expenditure in high potency APIs
3.1.2. Market Challenges
3.1.2.1. Handling and management of toxic HPAPIs
3.1.3. Market Opportunities
3.1.3.1. Rising cases of cancer-related diseases
Chapter 4. Global HPAPI Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political 
4.2.2. Economical
4.2.3. Social 
4.2.4. Technological 
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global HPAPI Market, by Product
5.1. Market Snapshot 
5.2. Global HPAPI Market by Product, Performance - Potential Analysis
5.3. Global HPAPI Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. HPAPI Market, Sub Segment Analysis
5.4.1. Synthetic
5.4.2. Biotech
Chapter 6. Global HPAPI Market, by Manufacturer
6.1. Market Snapshot 
6.2. Global HPAPI Market by Manufacturer, Performance - Potential Analysis
6.3. Global HPAPI Market Estimates & Forecasts by Manufacturer 2018-2027 (USD Billion)
6.4. HPAPI Market, Sub Segment Analysis
6.4.1. In-house
6.4.2. Outsourced
Chapter 7. Global HPAPI Market, by Drug Type
7.1. Market Snapshot 
7.2. Global HPAPI Market by Drug Type, Performance - Potential Analysis
7.3. Global HPAPI Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
7.4. HPAPI Market, Sub Segment Analysis
7.4.1. Innovative
7.4.2. Generic
Chapter 8. Global HPAPI Market, by Therapeutic
8.1. Market Snapshot 
8.2. Global HPAPI Market by Therapeutic, Performance - Potential Analysis
8.3. Global HPAPI Market Estimates & Forecasts by Therapeutic 2018-2027 (USD Billion)
8.4. HPAPI Market, Sub Segment Analysis
8.4.1.  Oncology
8.4.2. Hormonal
8.4.3. Glaucoma
8.4.4. Others
Chapter 9. Global HPAPI Market, Regional Analysis
9.1. HPAPI Market, Regional Market Snapshot 
9.2. North America HPAPI Market 
9.2.1. U.S. HPAPI Market
9.2.1.1. Product breakdown estimates & forecasts, 2018-2027 
9.2.1.2. Manufacturer breakdown estimates & forecasts, 2018-2027
9.2.1.3. Drug Type breakdown estimates & forecasts, 2018-2027
9.2.1.4. Therapeutic breakdown estimates & forecasts, 2018-2027
9.2.2. Canada HPAPI Market
9.3. Europe HPAPI Market Snapshot
9.3.1. U.K. HPAPI Market 
9.3.2. Germany HPAPI Market
9.3.3. France HPAPI Market
9.3.4. Spain HPAPI Market
9.3.5. Italy HPAPI Market
9.3.6. Rest of Europe HPAPI Market
9.4. Asia-Pacific HPAPI Market Snapshot
9.4.1. China HPAPI Market 
9.4.2. India HPAPI Market 
9.4.3. Japan HPAPI Market
9.4.4. Australia HPAPI Market
9.4.5. South Korea HPAPI Market
9.4.6. Rest of Asia Pacific HPAPI Market
9.5. Latin America HPAPI Market Snapshot
9.5.1. Brazil HPAPI Market
9.5.2. Mexico HPAPI Market
9.6. Rest of The World HPAPI Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1.  Eli Lilly and Company
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novartis AG
10.2.3. Bristol-Myers Squibb Company
10.2.4. Roche Diagnostics Ltd.
10.2.5. Sanofi
10.2.6. Hospira, Inc.
10.2.7. BASF SE
10.2.8. Covidien plc
10.2.9. Boehringer Ingelheim GmbH
10.2.10. Merck & Co., Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

Global HPAPI Market is valued approximately USD 21.08 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.00% over the forecast period 2021-2027. Active pharmaceutical ingredient is a raw substance or mixture of substances used in the manufacturing of a medicinal drug. An API is classified as an HPAPI if it has an occupational exposure limit at or below 10 micrograms per cubic meter of air. They have the ability to target the diseased cells more precisely and selectively than other APIs and hence are very crucial in diseases such as cancer. The higher demand for HPAPIs in the treatment of cancer patients, increasing investments from private and government players and growing focus on precision treatment are the major drivers for HPAPI market. Above mentioned advantages, coupled with the new technological development in manufacturing of HPAPI, are propelling the growth of the HPAPI market. The APIs are the crucial part of pharmaceutical industry. The significantly high growth of the industry after the COVID-19 pandemic has increased the demand of APIs. There was a huge disruption in pharmaceutical supply chain during lockdowns in pandemic which resulted in scarcity of APIs worldwide. The various governments, including Indian and other Asian countries, are now trying to upgrade the manufacturing of APIs domestically to reduce the reliance on China. These efforts are also driving the growth of high potency active pharmaceutical ingredients market. In 2020, the government of India announced Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of APIS, in which financial incentive will be given to qualified manufacturers of known 41 eligible products which covers 53 APIs for next 6 years. Another scheme from government allocates INR 3000 Crores for providing financial assistance for construction of common infrastructure facilities in 3 bulk drug parks across various states. High potency APIs are toxic in nature and thus require high level of care in their disposal. The issue in the management, storage and associated regulations with APIs may act as a restraint for its growth. However, increasing cases of cancer and other diseases requiring HPAPIs act as an opportunity for HPAPI Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of HPAPI Market. Due to higher demand in oncology treatment as well as higher per capita income, North America emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing number of cancer patients and increasing expenditure on healthcare facilities.

Major market player included in this report are:
Eli Lilly and Company
Novartis AG
Bristol-Myers Squibb Company
Roche Diagnostics Ltd.
Sanofi
Hospira, Inc.
BASF SE
Covidien plc
Boehringer Ingelheim GmbH
Merck & Co., Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Synthetic
Biotech

By Manufacturer:
In-house
Outsourced

By Drug-Type:
Innovative
Generic

By Therapeutic:
Oncology
Hormonal
Glaucoma
Others

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global HPAPI Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…